Balyasny Asset Management »

Sensei Biotherapeutics shares owned by Balyasny Asset Management

Quarter-by-quarter ownership of Sensei Biotherapeutics (SNSE) shares owned by Balyasny Asset Management from 13F filings

Historical chart of Balyasny Asset Management investment in Sensei Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sensei Biotherapeutics held by Balyasny Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sensei Biotherapeutics by Balyasny Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $511k 16k 31.52

More positions owned by Balyasny Asset Management

State Str Spdr S&p 500 Etf T Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Meta Platforms Cl A Call Option (META)
Amazon Call Option (AMZN)
NVIDIA Corporation Call Option (NVDA)
Apple Call Option (AAPL)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Warner Bros Discovery Com Ser A Put Option (WBD)
Raytheon Technologies Corp Call Option (RTX)
Select Sector Spdr Tr State Street Fin Call Option (XLFI)
Select Sector Spdr Tr State Street Ene Call Option (XLE)
Lumentum Hldgs Note 0.500% 6/1 (Principal)
Microsoft Corporation Call Option (MSFT)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)

View all positions for Balyasny Asset Management

Top funds holding Sensei Biotherapeutics

Vivo Capital
Cormorant Asset Management
Millennium Management
Franklin Resources
Stempoint Capital
Trails Edge Capital Partners
Goldman Sachs Group
Hrt Financial
Suvretta Capital Management
Bank of America Corporation
Logos Global Management
Boothbay Fund Management
Brevan Howard Capital Management
Fred Alger Management
Balyasny Asset Management

View all funds holding Sensei Biotherapeutics